TOP TIERMARKET NEWSWIRE
News & sentiment

ULTRAGENYX PHARMACEU (RARE) — News & AI sentiment

ULTRAGENYX PHARMACEU (RARE) news roundup. 1 story in the last 24 hours, 1 in the past week, 19 over 30 days. Average 24-hour sentiment is 50/100 — neutral (50 is neutral). Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 5 sales totalling $292K — net selling of $292K. US House Periodic Transaction Reports (90-day window): 2 purchases (~$16K) and 0 sales (~$0). Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
1
avg sentiment 50/100
7d stories
1
avg sentiment 50/100
30d stories
19
avg sentiment 56.7/100
Insider net (90d)
$292K
0 buys · 5 sells
Congress (90d)
2
2 buys · 0 sells

RARE news in the last 24 hours, 7 days, 30 days and 90 days

How much RARE coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowRARE storiesAvg AI sentimentRead
Last 24 hours150/100RARE headlines →
Last 7 days150/100RARE headlines →
Last 30 days1956.7/100RARE headlines →
Last 90 days14051.5/100RARE headlines →

Latest stories on RARE

17h ago
Oct 19
Oct 14
Oct 14
Oct 14
Oct 14
Oct 14
Oct 14
Oct 14
Oct 14
Oct 14
Oct 7
Oct 7
Oct 7
Oct 7
Oct 7
Oct 7
Oct 7
Oct 2
H.C. Wainwright reiterates Ultragenyx stock rating on FDA approval
Investing.com Analyst Ratings67 · bullishanalyst
Sep 25
Sep 23
Sep 22
Sep 22
Sep 21
Sep 21
Open RARE in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →